Buscar
Mostrando ítems 31-40 de 317
IL10 inversely correlates with the percentage of CD8(+) cells in MDS patients
(Pergamon-elsevier Science LtdOxfordInglaterra, 2013)
Updates in Cytogenetics and Molecular Markers in MDS
(Current Medicine GroupPhiladelphiaEUA, 2011)
Myelodysplastic syndromes in Latin America: State of the art
(American Society of Hematology, 2018-12)
Latin America is a group of countries that covers an area of approximately 19 197 000 km2. In 2016, itspopulation was estimated at more than 639 million. The prevalent languages are Spanish andPortuguese.Myelodysplastic ...
Cytogenetic studies of Brazilian pediatric myelodysplastic syndrome cases: challenges and difficulties in a large and emerging country
(Assoc Bras Divulg Cientifica, 2013-01-01)
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoietic stem cell diseases affecting children. Cytogenetics plays an important role in the diagnosis of these diseases. We report ...
Cytogenetic studies of Brazilian pediatric myelodysplastic syndrome cases: challenges and difficulties in a large and emerging country
(Associação Brasileira de Divulgação Científica (ABRADIC), 2013-01-11)
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoietic stem cell diseases affecting children. Cytogenetics plays an important role in the diagnosis of these diseases. We report ...
Síndromes mielodisplásicas e mielodisplásicas/mieloproliferativasMyelodysplastic syndromes and diseases with myelodysplastic and myeloproliferative features
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2009)
Treatment of pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: the Brazilian experience in the past decade
(Elsevier B.V., 2004-09-01)
Background: Therapy strategies for myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) vary considerably. Objective: To review the treatment of Brazilian children who were diagnosed with MDS or JMML ...
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish registry
(Nature Publishing Group, 2015)
Effects of thalidomide on long-term bone marrow cultures from patients with myelodysplastic syndromes: Induction of IL-10 expression in the stromal layers
(Pergamon-elsevier Science LtdOxfordInglaterra, 2011)